Horizons PBC, 7 E 7th Street, New York, NY (2026)

05/06/2024

We offer our thanks to Healing Breakthrough, a Supporting Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine.

Healing Breakthrough (HB) is a 501(c)(3) public charity working to provide all Veterans with PTSD who may benefit from access to safe, legal, high-quality M**A-Assisted Therapy (M**A-AT) through the VA. Through philanthropic funding, HB sponsors research, advocacy, training, and education to support an effort that will not only catalyze access to healing for thousands of Veterans but also contribute to the treatment’s clinical and social legitimacy, paving the way for other breakthrough therapies that have the potential to revolutionize mental healthcare within the VA and throughout American society.

You can learn more about Healing Breakthrough at https://buff.ly/3UPcdJx

We hope that you will join us and Healing Breakthrough in May at Horizons. View the agenda and register at https://buff.ly/3Egr4DU.

05/06/2024

On Saturday, May 11, we are pleased to welcome Christine Diindiisi McCleave, MA, Doctoral Student in Indigenous Studies, University of Alaska Fairbanks, Center for Cross-Cultural Studies, to the Horizons stage to as part of the “State initiatives to support psychedelic research and access” session.

A dramatic expansion of psychedelic policy activism is underway at the state level.

Over a dozen states have recently considered legislation addressing psychedelics, including bills proposing research funding, decriminalization, regulated adult use, and more. This session will share the variety of initiatives underway, and how legislators and activists consider and design strategies unique to their state.

Christine Diindiisi McCleave, enrolled citizen of the Turtle Mountain Ojibwe Nation, is the past CEO of the National Native American Boarding School Healing Coalition. She is currently a doctoral student in Indigenous Studies at the University of Alaska Fairbanks with a focus on entheogenic plant medicines and Indigenous knowledge systems. With a B.S. in communication studies and an M.A. in leadership, she conducted her master's thesis on Native American spirituality and Christianity and the spectrum of Native spiritual practices today including pe**te religion. She has pioneered an unprecedented national research scope, spoken at the UN in NY and Geneva, and helped write a bill for a truth and healing commission in the U.S. Her work continues to concentrate on the intersection of cultural, political, and spiritual agency for global Indigenous Rights and the healing of Indigenous historical trauma as a generational survivor of U.S. Indian Boarding Schools. She is also a member of the board for the Psychedelic Society of MN and lives in Minneapolis.

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at buff.ly/3Eoo2jd

05/03/2024

We offer our thanks to California Institute of Integral Studies, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine.

California Institute of Integral Studies (CIIS) is an accredited university that strives to embody spirit, intellect, and wisdom in service to individuals, communities, and the earth. CIIS expands the boundaries of traditional degree programs with transdisciplinary, cross-cultural, and applied studies utilizing face-to-face, hybrid, and online pedagogical approaches. Offering a personal learning environment and supportive community, CIIS provides an excellent multifaceted education for people committed to transforming themselves, others, and the world.

You can learn more about CIIS at ciis.edu.

We hope that you will join us and CIIS in May at Horizons. View the agenda and register at https://buff.ly/3Egr4DU.

05/03/2024

On Friday, May 10, we are pleased to welcome Psychedelic-Assisted Therapist and Psychotherapist Ivy Alvarez, PsyD, to the Horizons stage to as part of the “Listening to BIPOC Therapists” session.

As in many areas of clinical research and care, ethnic and racial minorities are underrepresented in studies of psychedelic-assisted therapy (PAT), hindering generalization of reported treatment outcomes as well as the opportunity to develop accessible, culturally-informed treatment models in our multi-cultural society. Increasing the diversity of psychedelic therapists and researchers might contribute to address this issue. However, little is known about how therapists of colors view their potential role in this field, and what opportunities and barriers they identify.

This session will present The Psychedelic Therapists Diversity study, which will explore, through qualitative methods, opportunities and barriers for therapists of colors to engage in PAT and research.

Dr. Alvarez earned her Psy.D from the California School of Professional Psychology, and her academic journey was marked by a deep immersion in both traditional and contemporary approaches to therapy. Throughout her doctoral research, Ivy embarked on a transformative journey across Ecuador, Peru, Colombia, and the Sierra Mountains in Oaxaca, Mexico. Here, she engaged in profound dialogues and experiences with Indigenous healers, delving into their perspectives on plant medicine. This immersive exploration not only enriched her dissertation but also profoundly shaped her understanding of healing practices.

In her dissertation, Dr. Alvarez focused on amplifying the voices of psychedelic-assisted therapists, particularly highlighting the perspectives and cultures surrounding their practices. She provided a platform for practitioners to share their wisdom lineage and advocated for inclusive approaches that center on the needs of BIPOC/Indigenous populations. Through her work, Ivy seeks to bridge cultural divides and promote healing practices that are both inclusive and culturally sensitive.

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

05/02/2024

On Saturday, May 11, we are pleased to welcome Tamar Todd, Legal Counsel, New Approach, to the Horizons stage to as part of the “State initiatives to support psychedelic research and access” session.

A dramatic expansion of psychedelic policy activism is underway at the state level.

Over a dozen states have recently considered legislation addressing psychedelics, including bills proposing research funding, decriminalization, regulated adult use, and more. This session will share the variety of initiatives underway, and how legislators and activists consider and design strategies unique to their state.

Tamar Todd is an attorney with expertise in policy advocacy, legislative drafting, ballot initiatives, statewide political campaign strategy, regulatory implementation, and non-profit management in the areas of drug law reform, public health, and criminal justice. She is a lecturer in cannabis law and policy at Berkeley Law, and was the former legal director at the Drug Policy Alliance.

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

04/28/2024

Horizons: Perspectives on Psychedelics will be at the historic New York Academy of Medicine.

This is our second year hosting Horizons New York in this special place, and our first year spending the full four days there. Established in 1847, the New York Academy of Medicine (NYAM) has been at the forefront of medical research, education, and advocacy for over 175 years.

The building itself is a cultural landmark on the Upper East Side, featuring architectural significance and historical charm. The NYAM library and archives house valuable collections of rare books, manuscripts, and artifacts, preserving the heritage of medicine and healthcare. The library is one of the three largest in the United States and is open to the public, especially curious Horizons New York attendees.

We are honored to spend four days in this venerable space, starting with workshops on Wednesday and then launching into the conference on Thursday. Won’t you join us?

*Photo attribution: Beyond My Ken, public domain, via Wikimedia Commons

04/28/2024

On Friday, May 10, we are pleased to welcome Candace Oglesby, LCPC, Psychotherapist, Jurnee Mental Health Consulting, to the Horizons stage to as part of the “Listening to BIPOC Therapists” session.

As in many areas of clinical research and care, ethnic and racial minorities are underrepresented in studies of psychedelic-assisted therapy (PAT), hindering generalization of reported treatment outcomes as well as the opportunity to develop accessible, culturally-informed treatment models in our multi-cultural society. Increasing the diversity of psychedelic therapists and researchers might contribute to address this issue. However, little is known about how therapists of colors view their potential role in this field, and what opportunities and barriers they identify.

This session will present The Psychedelic Therapists Diversity study, which will explore, through qualitative methods, opportunities and barriers for therapists of colors to engage in PAT and research.

Candace Oglesby is the program director of a Ketamine Assisted Psychotherapy certificate program. Her specialization lies in working with diverse adult populations, with a specific focus on trauma survivors, particularly women of color. She has also served as a DEI consultant to some of the top psychedelic companies in the industry. As the founder of Jurnee Mental Health Consulting, LLC, Candace leads a consulting business dedicated to supporting individuals and businesses in deepening their understanding of mental health. Her focus extends in providing resources and support to historically marginalized and global majority communities.

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

04/26/2024

We offer our thanks to Psychedelic Health Equity Initiative, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine.

The Psychedelic Health Equity Initiative (PHEI) strives to enhance the well-being of marginalized individuals by promoting equitable access to effective psychedelic medicines and therapies. Our mission is to develop tools for increased access to psychedelic-assisted therapy (PAT) in marginalized communities. Through our field map and database, we aim to boost visibility and connections among leaders and organizations driving the psychedelic health equity movement. We actively seek collaboration with community leaders, service providers, and organizations involved in PAT equity and access. Acknowledging that collaboration and learning are crucial, we recognize the value of engaging with diverse communities. Our primary objectives include identifying philanthropic investment opportunities to fund demonstration projects, encouraging broader support from governments, private sectors, and foundations for equitable access in marginalized communities.

You can learn more about PHEI at https://buff.ly/3UBdlkI.

We hope that you will join us and PHEI in May at Horizons. View the agenda and register at https://buff.ly/3Egr4DU.

04/26/2024

On Friday, May 10, we are pleased to welcome Tehseen Noorani, PhD, Senior Research Fellow, University of Auckland, to the Horizons stage to discuss “the enigma of psychedelic trial design.”

Dr. Noorani joins Harriet de Wit, PhD, and Natalie Gukasyan, MD, as they consider the complexities of trial designs for studies of psychedelic drugs and treatments.

Psychedelics are a sui generis class of drugs whose effects and best practices were not anticipated by typical regulatory assumptions and trial designs.

What lessons have scientists learned from decades of research and data, and how will the next generation of trials and studies offer more robust findings and valuable data?

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

04/25/2024

There are just a few days left to register for Horizons New York at the current price tier. On May 1 prices will increase, followed by an additional increase on May 6 (show week).

If you have friends, colleagues, or loved ones that would like to attend Horizons, please encourage them to register ASAP. The conference has sold out in the past. Advance registration is highly recommended, including for day passes.

We hope you plan to join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

04/24/2024

We offer our thanks to Fluence, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine.

Fluence is the premier continuing education organization in the emerging field of psychedelic therapy, founded by clinicians with deep expertise in psychedelic research.

You can learn more about Fluence at fluencetraining.com.

We hope that you will join us and Fluence in May at Horizons. View the agenda and register at https://buff.ly/3Egr4DU.

04/23/2024

On Thursday, May 9, we are pleased to welcome Dr. Kelley O’Donnell, MD, PhD, to the Horizons stage to as part of a session about “Educating the next generation of psychedelic therapists.”

The presence of a skilled psychedelic facilitator and the establishment of rapport are key elements in the positive therapeutic outcomes. Ensuring high-quality industry-wide standards of training will be a priority for the success of this treatment modality. Dr. O’Donnell will join NiCole T. Buchanan, PhD, as they consider and share strategies for preparing the next generation of psychedelic facilitators.

Dr. Kelley O’Donnell is a board-certified psychiatrist and an Assistant Professor of Psychiatry at the NYU School of Medicine, where she is the Director of Clinical Training at the NYU Langone Center for Psychedelic Medicine. She has advanced training and extensive experience working with psilocybin, M**A, and ketamine. In addition to her work as a co-investigator, psychedelic therapist, and clinical supervisor on a number of clinical trials, she is involved in psychedelic curriculum development initiatives, and teaches extensively on topics related to psychedelic medicine and integrative psychotherapy.

Join us for three days of learning and networking at Horizons on May 8-11, 2024. Explore our agenda, speaker lineup, and register at https://buff.ly/3Egr4DU

Horizons PBC

05/06/2024

05/06/2024

05/03/2024

05/03/2024

05/02/2024

04/28/2024

04/28/2024

04/26/2024

04/26/2024

04/25/2024

04/24/2024

04/23/2024

Address

Website

Alerts

Contact The Organization

Shortcuts

Featured

Share

Category